The acquisition includes CAPLYTA® (lumateperone), the only FDA-approved treatment for bipolar I and II depression, as well as schizophrenia, and a supplemental new drug application has been ...

As the company approaches critical data readouts, investors and analysts are closely watching its progress in the competitive landscape of chronic urticaria treatments. InvestingPro analysis reveals ...

As the company approaches critical data readouts, investors and analysts are closely watching its progress in the competitive landscape of chronic urticaria treatments. InvestingPro analysis reveals ...

Moisturizing your baby’s skin regularly and using gentle cleansers can help to prevent flare-ups. Topical treatments such as corticosteroids may be prescribed by your pediatrician to relieve symptoms.